Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

How can we ensure temperature compliance during transport of medicines requiring cold chain transport?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q377 · Category H: Licensed operations and routine regulatory oversight (Q351–Q400)
Ensuring compliant transport temperatures for cold-chain medicines requires a systematic approach to validation and monitoring. First, you need to conduct “transport validation”. This means demonstrating that your chosen transport route, packaging solution (such as insulated boxes and ice packs) and transport equipment can keep the medicines within the specified temperature range, usually 2–8°C, even under worst-case conditions, such as the hottest summer weather and the longest transport time. This is usually done by placing multiple temperature loggers inside the transport containers and conducting actual or simulated transport. Second, a calibrated, independent temperature logger must be used to monitor the goods’ temperature throughout every actual shipment. On receipt, the recipient must check the temperature records immediately and may accept the goods only after confirming that the temperature remained within range throughout. Any temperature excursion must be investigated as a deviation.

📘 Regulatory basis

Both the Code of Practice for Licensed Wholesale Dealers and the PIC/S GDP guidelines set very high standards for the transportation of cold-chain medicines, emphasising that transport conditions must be validated and monitored to ensure that medicine quality is not affected during transportation.

📗 Drew Tang's recommendations

We recommend that clients use a “qualified” cold-chain packaging solution that has been validated in advance. Many specialist suppliers on the market provide such services. When working with a transport company, its responsibilities for cold-chain transport must be clearly specified in the contract or quality agreement. It is equally important to provide dedicated training for drivers so that they understand the importance of cold-chain medicines and the emergency procedures to follow in the event of an incident (such as vehicle failure).

📕 Risk notice

Cold-chain interruptions are one of the main causes of failure of medicines such as costly biological products. A single temperature excursion may mean that medicines worth millions must be destroyed. If cold-chain medicines are transported without transport validation or continuous temperature monitoring, the Department of Health may treat this as a critical deficiency if discovered, because you would be completely unable to demonstrate that the medicines were in acceptable condition when delivered to the customer.

Back to Category H: Licensed Operations and Routine Oversight (Q351-Q400) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗